2021
DOI: 10.7150/jca.49203
|View full text |Cite
|
Sign up to set email alerts
|

The essential role of long non-coding RNA GAS5 in glioma: interaction with microRNAs, chemosensitivity and potential as a biomarker

Abstract: Glioma is a malignant brain tumor with a generally poor prognosis. Dysregulation of a long non-coding RNA, GAS5, has been detected in numerous cancers, including glioma. Previous studies have suggested that GAS5 plays a significant functional role in glioma, affecting proliferation, metastasis, invasion, and apoptosis. In this review, we describe the roles and mechanisms of GAS5 in glioma. GAS5 may be a biomarker for diagnosis and prognosis, and even a potential target for glioma treatment, and therefore warra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 67 publications
0
10
0
Order By: Relevance
“…Numerous lncRNAs have also been reported to be involved in the malignant progression of glioma. For example, GAS5 and HOTAIR were dysregulated in gliomas and related to the proliferation, migration, invasion and chemosensitivity of glioma cells [28,[35][36][37]. FGF14-AS2 was reported to function as a suppressor gene in breast cancer and colorectal cancer [13,15]; however, its role in glioma has not been reported to date.…”
Section: Discussionmentioning
confidence: 99%
“…Numerous lncRNAs have also been reported to be involved in the malignant progression of glioma. For example, GAS5 and HOTAIR were dysregulated in gliomas and related to the proliferation, migration, invasion and chemosensitivity of glioma cells [28,[35][36][37]. FGF14-AS2 was reported to function as a suppressor gene in breast cancer and colorectal cancer [13,15]; however, its role in glioma has not been reported to date.…”
Section: Discussionmentioning
confidence: 99%
“…Another example is TUG1 , which sequesters miR-29b-3p , miR-29c , miR-133b , and miR-590 [ 45 , 46 , 51 , 52 ]. As there are more miRNAs being identified to bind these two exemplified lncRNAs in other cell types (e.g., cardiomyocytes, endothelial cells), cellular statuses, and diseases [ 51 , 52 , 53 , 54 , 55 , 56 , 57 ], it is important to perform a comparative study of lncRNAs and several miRNAs being reported to be sequestered by the target lncRNAs by measuring the copy numbers of each RNA species. Without such a head-to-head comparative study, more and more miRNAs will be reported to be sequestered by one lncRNA, despite its expression level being far lower than those of the sequestered miRNAs.…”
Section: Lncrnas In Cardiac Fibrosismentioning
confidence: 99%
“… 3 , 4 Long noncoding RNAs can act as oncogenes (such as HOX transcript antisense RNA) 5 or tumor suppressors (such as growth arrest‐specific transcript 5 [GAS5]). 6 Evidence shows that GAS5 is abnormally expressed in a variety of cancers, such as non‐small‐cell lung cancer, hepatocellular carcinoma, breast cancer, and gastric cancer. 7 , 8 , 9 , 10 However, the function and mechanism of GAS5 in EC are largely unknown.…”
Section: Introductionmentioning
confidence: 99%
“…Increasing evidence has shown that abnormal expression of certain lncRNAs could play an important function in cancer biology 3,4 . Long noncoding RNAs can act as oncogenes (such as HOX transcript antisense RNA) 5 or tumor suppressors (such as growth arrest‐specific transcript 5 [GAS5]) 6 . Evidence shows that GAS5 is abnormally expressed in a variety of cancers, such as non‐small‐cell lung cancer, hepatocellular carcinoma, breast cancer, and gastric cancer 7‐10 .…”
Section: Introductionmentioning
confidence: 99%